Report Detail

Request for Sample of this report

Other Global Chronic Spontaneous Urticaria Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4517847
    • |
  • 06 March, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Chronic Spontaneous Urticaria market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Chronic Spontaneous Urticaria market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chronic Spontaneous Urticaria market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chronic Spontaneous Urticaria market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chronic Spontaneous Urticaria market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chronic Spontaneous Urticaria market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Spontaneous Urticaria
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Spontaneous Urticaria market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan N. V., Sanofi, GlaxoSmithKline, Bayer and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Chronic Spontaneous Urticaria market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antihistamine
Monoclonal Antibody
Other
Market segment by Application
Children
Adult
Market segment by players, this report covers
Mylan N. V.
Sanofi
GlaxoSmithKline
Bayer
Merck
Aurobindo Pharma
Hikma Pharmaceuticals
WOCKHARDT
AbbVie, Inc.
Cipla Inc.
F. Hoffmann La Roche Ltd.
Teva Pharmaceutical Industries, Ltd.
Pfizer, Inc.
Novartis AG
Eli Lilly and Company
Allergan
Lupin
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Spontaneous Urticaria product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Spontaneous Urticaria, with revenue, gross margin and global market share of Chronic Spontaneous Urticaria from 2018 to 2023.
Chapter 3, the Chronic Spontaneous Urticaria competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chronic Spontaneous Urticaria market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Spontaneous Urticaria.
Chapter 13, to describe Chronic Spontaneous Urticaria research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Chronic Spontaneous Urticaria
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Chronic Spontaneous Urticaria by Type
    • 1.3.1 Overview: Global Chronic Spontaneous Urticaria Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Chronic Spontaneous Urticaria Consumption Value Market Share by Type in 2022
    • 1.3.3 Antihistamine
    • 1.3.4 Monoclonal Antibody
    • 1.3.5 Other
  • 1.4 Global Chronic Spontaneous Urticaria Market by Application
    • 1.4.1 Overview: Global Chronic Spontaneous Urticaria Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Children
    • 1.4.3 Adult
  • 1.5 Global Chronic Spontaneous Urticaria Market Size & Forecast
  • 1.6 Global Chronic Spontaneous Urticaria Market Size and Forecast by Region
    • 1.6.1 Global Chronic Spontaneous Urticaria Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Chronic Spontaneous Urticaria Market Size by Region, (2018-2029)
    • 1.6.3 North America Chronic Spontaneous Urticaria Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Chronic Spontaneous Urticaria Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Chronic Spontaneous Urticaria Market Size and Prospect (2018-2029)
    • 1.6.6 South America Chronic Spontaneous Urticaria Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Chronic Spontaneous Urticaria Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Mylan N. V.
    • 2.1.1 Mylan N. V. Details
    • 2.1.2 Mylan N. V. Major Business
    • 2.1.3 Mylan N. V. Chronic Spontaneous Urticaria Product and Solutions
    • 2.1.4 Mylan N. V. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Mylan N. V. Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Chronic Spontaneous Urticaria Product and Solutions
    • 2.2.4 Sanofi Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 GlaxoSmithKline
    • 2.3.1 GlaxoSmithKline Details
    • 2.3.2 GlaxoSmithKline Major Business
    • 2.3.3 GlaxoSmithKline Chronic Spontaneous Urticaria Product and Solutions
    • 2.3.4 GlaxoSmithKline Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Chronic Spontaneous Urticaria Product and Solutions
    • 2.4.4 Bayer Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Chronic Spontaneous Urticaria Product and Solutions
    • 2.5.4 Merck Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Merck Recent Developments and Future Plans
  • 2.6 Aurobindo Pharma
    • 2.6.1 Aurobindo Pharma Details
    • 2.6.2 Aurobindo Pharma Major Business
    • 2.6.3 Aurobindo Pharma Chronic Spontaneous Urticaria Product and Solutions
    • 2.6.4 Aurobindo Pharma Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Aurobindo Pharma Recent Developments and Future Plans
  • 2.7 Hikma Pharmaceuticals
    • 2.7.1 Hikma Pharmaceuticals Details
    • 2.7.2 Hikma Pharmaceuticals Major Business
    • 2.7.3 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Product and Solutions
    • 2.7.4 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Hikma Pharmaceuticals Recent Developments and Future Plans
  • 2.8 WOCKHARDT
    • 2.8.1 WOCKHARDT Details
    • 2.8.2 WOCKHARDT Major Business
    • 2.8.3 WOCKHARDT Chronic Spontaneous Urticaria Product and Solutions
    • 2.8.4 WOCKHARDT Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 WOCKHARDT Recent Developments and Future Plans
  • 2.9 AbbVie, Inc.
    • 2.9.1 AbbVie, Inc. Details
    • 2.9.2 AbbVie, Inc. Major Business
    • 2.9.3 AbbVie, Inc. Chronic Spontaneous Urticaria Product and Solutions
    • 2.9.4 AbbVie, Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 AbbVie, Inc. Recent Developments and Future Plans
  • 2.10 Cipla Inc.
    • 2.10.1 Cipla Inc. Details
    • 2.10.2 Cipla Inc. Major Business
    • 2.10.3 Cipla Inc. Chronic Spontaneous Urticaria Product and Solutions
    • 2.10.4 Cipla Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Cipla Inc. Recent Developments and Future Plans
  • 2.11 F. Hoffmann La Roche Ltd.
    • 2.11.1 F. Hoffmann La Roche Ltd. Details
    • 2.11.2 F. Hoffmann La Roche Ltd. Major Business
    • 2.11.3 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Product and Solutions
    • 2.11.4 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 F. Hoffmann La Roche Ltd. Recent Developments and Future Plans
  • 2.12 Teva Pharmaceutical Industries, Ltd.
    • 2.12.1 Teva Pharmaceutical Industries, Ltd. Details
    • 2.12.2 Teva Pharmaceutical Industries, Ltd. Major Business
    • 2.12.3 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Product and Solutions
    • 2.12.4 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Teva Pharmaceutical Industries, Ltd. Recent Developments and Future Plans
  • 2.13 Pfizer, Inc.
    • 2.13.1 Pfizer, Inc. Details
    • 2.13.2 Pfizer, Inc. Major Business
    • 2.13.3 Pfizer, Inc. Chronic Spontaneous Urticaria Product and Solutions
    • 2.13.4 Pfizer, Inc. Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Pfizer, Inc. Recent Developments and Future Plans
  • 2.14 Novartis AG
    • 2.14.1 Novartis AG Details
    • 2.14.2 Novartis AG Major Business
    • 2.14.3 Novartis AG Chronic Spontaneous Urticaria Product and Solutions
    • 2.14.4 Novartis AG Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Novartis AG Recent Developments and Future Plans
  • 2.15 Eli Lilly and Company
    • 2.15.1 Eli Lilly and Company Details
    • 2.15.2 Eli Lilly and Company Major Business
    • 2.15.3 Eli Lilly and Company Chronic Spontaneous Urticaria Product and Solutions
    • 2.15.4 Eli Lilly and Company Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.16 Allergan
    • 2.16.1 Allergan Details
    • 2.16.2 Allergan Major Business
    • 2.16.3 Allergan Chronic Spontaneous Urticaria Product and Solutions
    • 2.16.4 Allergan Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Allergan Recent Developments and Future Plans
  • 2.17 Lupin
    • 2.17.1 Lupin Details
    • 2.17.2 Lupin Major Business
    • 2.17.3 Lupin Chronic Spontaneous Urticaria Product and Solutions
    • 2.17.4 Lupin Chronic Spontaneous Urticaria Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Lupin Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Chronic Spontaneous Urticaria Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Chronic Spontaneous Urticaria by Company Revenue
    • 3.2.2 Top 3 Chronic Spontaneous Urticaria Players Market Share in 2022
    • 3.2.3 Top 6 Chronic Spontaneous Urticaria Players Market Share in 2022
  • 3.3 Chronic Spontaneous Urticaria Market: Overall Company Footprint Analysis
    • 3.3.1 Chronic Spontaneous Urticaria Market: Region Footprint
    • 3.3.2 Chronic Spontaneous Urticaria Market: Company Product Type Footprint
    • 3.3.3 Chronic Spontaneous Urticaria Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Chronic Spontaneous Urticaria Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Chronic Spontaneous Urticaria Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Chronic Spontaneous Urticaria Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Chronic Spontaneous Urticaria Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Chronic Spontaneous Urticaria Consumption Value by Type (2018-2029)
  • 6.2 North America Chronic Spontaneous Urticaria Consumption Value by Application (2018-2029)
  • 6.3 North America Chronic Spontaneous Urticaria Market Size by Country
    • 6.3.1 North America Chronic Spontaneous Urticaria Consumption Value by Country (2018-2029)
    • 6.3.2 United States Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Chronic Spontaneous Urticaria Consumption Value by Type (2018-2029)
  • 7.2 Europe Chronic Spontaneous Urticaria Consumption Value by Application (2018-2029)
  • 7.3 Europe Chronic Spontaneous Urticaria Market Size by Country
    • 7.3.1 Europe Chronic Spontaneous Urticaria Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 7.3.3 France Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Chronic Spontaneous Urticaria Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Chronic Spontaneous Urticaria Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Chronic Spontaneous Urticaria Market Size by Region
    • 8.3.1 Asia-Pacific Chronic Spontaneous Urticaria Consumption Value by Region (2018-2029)
    • 8.3.2 China Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 8.3.5 India Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Chronic Spontaneous Urticaria Consumption Value by Type (2018-2029)
  • 9.2 South America Chronic Spontaneous Urticaria Consumption Value by Application (2018-2029)
  • 9.3 South America Chronic Spontaneous Urticaria Market Size by Country
    • 9.3.1 South America Chronic Spontaneous Urticaria Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Chronic Spontaneous Urticaria Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Chronic Spontaneous Urticaria Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Chronic Spontaneous Urticaria Market Size by Country
    • 10.3.1 Middle East & Africa Chronic Spontaneous Urticaria Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Chronic Spontaneous Urticaria Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Chronic Spontaneous Urticaria Market Drivers
  • 11.2 Chronic Spontaneous Urticaria Market Restraints
  • 11.3 Chronic Spontaneous Urticaria Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Chronic Spontaneous Urticaria Industry Chain
  • 12.2 Chronic Spontaneous Urticaria Upstream Analysis
  • 12.3 Chronic Spontaneous Urticaria Midstream Analysis
  • 12.4 Chronic Spontaneous Urticaria Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Chronic Spontaneous Urticaria. Industry analysis & Market Report on Chronic Spontaneous Urticaria is a syndicated market report, published as Global Chronic Spontaneous Urticaria Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Chronic Spontaneous Urticaria market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,212.04
    		4,818.06
    		6,424.08
    		546,394.80
    		819,592.20
    		1,092,789.60
    		289,222.80
    		433,834.20
    		578,445.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo